Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight
October 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight The rise in research and development activities in...
Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities
February 16, 2021 20:15 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities Doria and ALKS...